新闻
- Anavex Life Sciences Provides Supplemental Information on ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial for the Treatment of Adult Patients with Rett Syndrome
04.02.2022 / 13:00 - GlobeNewswire
-
- Patriot Battery Metals Drills 1.25% Li2O over 58.1 m, including 1.80% Li2O over 33.0 m, in Third Hole at the Corvette-FCI Property, James Bay, QC
03.02.2022 / 14:00 - GlobeNewswire
-
- Timber Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA for TMB-001 in Moderate to Severe Congenital Ichthyosis
03.02.2022 / 14:00 - GlobeNewswire
-
- Daniels Fund gives $60.5 million in grants and scholarships in 2021
02.02.2022 / 16:34 - GlobeNewswire
-
- MHS wins award for robotics designed to address e-commerce demands in parcel logistics warehouses
02.02.2022 / 15:30 - GlobeNewswire
-
- ROHM’s New Ultra-High Efficiency Battery Management Solution Evaluation Board for Thin, Compact IoT Devices
01.02.2022 / 23:00 - GlobeNewswire
-
- Laser Scanning Cargo Wrapped in Black Plastic is Now Obsolete
01.02.2022 / 16:00 - GlobeNewswire
-
- Checkmate Pharmaceuticals Welcomes Industry Leader Jon Wigginton, M.D. to its Board of Directors
31.01.2022 / 22:30 - GlobeNewswire
-
- Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upcoming SIMD and GMDI Conferences
27.01.2022 / 14:30 - GlobeNewswire
-
- Patriot Battery Metals Drills 0.94% Li2O over 155.1 m, including 1.38% Li2O over 38.0 m, in Second Drill Hole at the Corvette-FCI Property, James Bay, QC
27.01.2022 / 14:00 - GlobeNewswire